MedTrace Logo

Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid

NCT01693055 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2014-04-07

No results posted yet for this study

Summary

Study title

* Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid Study design
* single arm and Investigator Initiative pilot study

Conditions

  • Orbital Fat Prolapse

Interventions

DEVICE

UltheraTM 100 shots

UltheraTM 100 shots (infraorbital region 30shots, lateral orbital region 40shots, upper eyelid 30 shots) on the Rt, and Lt periorbital area, respectively using 1.5mm and 3.0mm probe

Sponsors & Collaborators

  • Ulthera, Inc

    collaborator INDUSTRY

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Chanyeong Heo, Ph.D · Seoul National University Bundang Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01693055 on ClinicalTrials.gov